MDMA & Psilocybin Reverse Long-COVID Symptoms: The Case Report Explained
A podcast breaking down the published clinical case report of a Long-COVID patient whose persistent fatigue, brain fog, and post-exertional malaise substantially resolved following MDMA and psilocybin-assisted therapy — examining proposed mechanisms and what this single case means for the emerging research agenda.
Source Research Papers
Citations in APA 7 format. All studies were sourced from peer-reviewed journals via Google Scholar. Unfamiliar terms? See the plain-language glossary →
Chopra, H., Furnish, T., Verduzco-Gutierrez, M., Jevotovsky, D. S., & Castellanos, J. (2024). Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report. Clinical Case Reports, 12, e8791. https://doi.org/10.1002/ccr3.8791
One patient with long-COVID fatigue and brain fog improved after psilocybin and MDMA therapy. A single case can't prove cause and effect, but it opens a question worth studying.
Shop Related Spores
Laboratory-grade Psilocybe cubensis spore syringes for microscopy research.